Abstract
The aim of the study was to determine whether cavernous nerve preservation in men with prostate cancer and preoperative poor erectile function is a worthwhile endeavor. This is a retrospective analysis of prospectively collected data of 1,160 patients comparing erectile function pre- and postoperatively with 2 years of follow-up. Sexual Health Inventory for Men–International Index of Erectile Function 5 (SHIM-IIEF-5) questionnaire was used for assessment of erectile dysfunction preoperatively and at 6, 12, and 24 months postoperatively. IIEF < 13 was considered for inclusion. Bilateral nerve-sparing (BNS, n = 33) versus non-nerve-sparing (NNS, n = 32) procedures were compared. Continence data was collected. All men were offered penile rehabilitation therapy. Average preoperative IIEF-5 scores were 5.45 (BNS) and 4.28 (NNS) and not statistically significant. At 2 years, the average post-op IIEF scores were 4.91 (BNS) and 2.06 (NNS). This was a statistically significant decline in the NNS group. Most erectile function was recovered by 1 year. Positive surgical margins were not statistically significant between groups. Continence was improved in the BNS group (78 vs. 50 %, p = 0.047). Nerve sparing appears to be a worthwhile endeavor in men with poor preoperative IIEF as they return to baseline, oncologic outcomes are not compromised, and may have a continence benefit. The decision for an NNS procedure should not be made on the patient’s preoperative erectile function, but on the merits of other indicators such as grade or advanced clinical stage.
Similar content being viewed by others
References
Public Health Agency of Canada. http://www.phac-aspc.gc.ca/cd-mc/cancer/prostate_cancer-cancer_prostate-eng.php
SEER Prostate Cancer fact sheet. http://seer.cancer.gov/statfacts/html/prost.html
Walsh PC, Lepor H, Eggleston JC (1983) Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 4:473–485
Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M, Guazzoni G, Guillonneau B, Menon M, Montorsi F, Patel V, Rassweiler J, Van Poppel H (2009) Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 55(5):1037–1063
Savera AT, Kaul S, Badani K, Stark AT, Shah NL, Menon M (2006) Robotic radical prostatectomy with the “Veil of Aphrodite” technique: histologic evidence of enhanced nerve sparing. Eur Urol 49:1065–1074
Tewari A, Rao S, Martinez-Salamanca JI, Leung R, Ramanathan R, Mandhani A, Vaughan ED, Menon M, Horninger W, Tu J, Bartsch G (2008) Cancer control and the preservation of neurovascular tissue: how to meet competing goals during robotic radical prostatectomy. BJU Int 101:1013–1018
Masterson TA, Serio AM, Mulhall JP, Vickers AJ, Eastham JA (2008) Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function. BJU Int 101(10):1217–1222
Gratzke C, Strong TD, Gebska MA, Champion HC, Stief CG, Burnett AL, Bivalacqua TJ (2010) Activated RhoA/Rho kinase impairs erectile function after cavernous nerve injury in rats. J Urol 184:2197–2204
Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, Abdel-Mageed AB, Hellstrom WJ (2003) Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 24:239–245
User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT (2003) Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 169:1175–1179
Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V (2005) Histological alterations in cavernous tissue after radical prostatectomy. J Urol 173:1673–1676
Patel VR, Sivaraman A, Coelho RF, Chauhan S, Palmer KJ, Orvieto MA, Camacho I, Coughlin G, Rocco B (2011) Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol 59(5):702–707
Ficarra V, Novara G, Ahlering TE, Costello A, Eastham JA, Graefen M, Guazzoni G, Menon M, Mottrie A, Patel VR, Van der Poel H, Rosen RC, Tewari AK, Wilson TG, Zattoni F, Montorsi F (2012) Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 62(3):418–430
Menon M, Tewari A, Baize B, Guillonneau B, Vallancien G (2002) Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: the Vattikuti Urology Institute experience. Urology 60(5):864–868
Chawla A, Qureshi A, Alamri A, Matsumoto ED (2012) Optimal port placement during laparoscopic radical prostatectomy. Can J Urol 19(1):6142–6146
Chin JL, Luke PP, Pautler SE (2007) Initial experience with robotic-assisted laparoscopic radical prostatectomy in the Canadian health care system. Can Urol Assoc J 1(2):97–101
Kaouk JH, Goel RK, Haber GP, Crouzet S, Desai MM, Gill IS (2008) Single-port laparoscopic radical prostatectomy. Urology 72(6):1190–1193
Secin FP, Savage C, Abbou C, de La Taille A, Salomon L, Rassweiler J, Hruza M, Rozet F, Cathelineau X, Janetschek G, Nassar F, Turk I, Vanni AJ, Gill IS, Koenig P, Kaouk JH, Martinez Pineiro L, Pansadoro V, Emiliozzi P, Bjartell A, Jiborn T, Eden C, Richards AJ, Van Velthoven R, Stolzenburg JU, Rabenalt R, Su LM, Pavlovich CP, Levinson AW, Touijer KA, Vickers A, Guillonneau B (2010) The learning curve for laparoscopic radical prostatectomy: an international multicenter study. J Urol 184(6):2291–2296
Martínez CH, Chalasani V, Lim D, Nott L, Al-Bareeq RJ, Wignall GR, Stitt L, Pautler SE (2010) Effect of prostate gland size on the learning curve for robot-assisted laparoscopic radical prostatectomy: does size matter initially? J Endourol 24(2):261–266
Coelho RF, Rocco B, Patel MB, Orvieto MA, Chauhan S, Ficarra V, Melegari S, Palmer KJ, Patel VR (2010) Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol 24(12):2003–2015
Nelson CJ, Scardino PT, Eastham JA, Mulhall JP (2013) Back to baseline: erectile function recovery after radical prostatectomy from the patients’ perspective. J Sex Med 10:1636–1643
Harris CR, Punnen S, Carroll PR (2013) Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy. J Urol 190(3):981–986
Stember MD, Nelson CJ, Mulhall JP (2013) Preoperative erectile function is an independent predictor for decision to spare cavernous nerves during radical prostatectomy. J Sex Med 10:2101–2107
Porst H, Burnett A, Brock G, Ghanem H, Giuliano F, Glina S, Hellstrom W, Martin-Morales A, Salonia A, Sharlip I, ISSM Standards Committee for Sexual Medicine (2013) SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med 10(1):130–171
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49(6):822–830
Rosen RC, Capelleri JC, Smith MD, Lipsky J, Pena BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326
Jonker-Pool G, Van De Wiel HBM, Hoekstra HJ, Sleijfer DT, Van Driel MF, Van Basten JP, Koops HS (2001) Sexual functioning after treatment for testicular cancer—review and meta-analysis of 36 empirical studies between 1975–2000. Arch Sex Behav 30(1):55–74
Zhang X, Morelli A, Luocni M, Vignozzi L, Filippi S, Marini M, Vanelli GB, Mancina R, Forti G, Maggi M (2005) Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol 47(3):409–416
Greco EA, Spera G, Aversa A (2006) Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. Eur Urol 50(5):940–947
Garcia FJ, Brock G (2010) Current state of penile rehabilitation after radical prostatectomy. Curr Opin Urol 20(3):234–240
Montorsi F et al (2008) Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 54:924–931
Montorsi F et al (2004) Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 172:1036–1041
Conflict of interest
Authors FJG, PDV, and EDM declare no conflicts of interest. Author SEP declares unrestricted educational Grants from Paladin Labs, Urologic Cook, and Astra Zeneca. Author GBB declares Advisory board, stock, and speakers bureau for J&J, Coloplast, AMS, Pfizer, Lilly, Bayer, and GSK.
Ethical standard
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5).
Informed consent
Informed consent was obtained from all patients for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Garcia, F.J., Violette, P.D., Matsumoto, E.D. et al. Nerve-sparing prostatectomy benefits men with poor preoperative erectile dysfunction. J Robotic Surg 8, 299–304 (2014). https://doi.org/10.1007/s11701-014-0469-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11701-014-0469-9